Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.7 |
mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |